R Squared’s Mesoblast MESO Stock Holding History

R Squared’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,571	Closed	-$126K	–	645
2025 Q2	$126K	Buy	+11,571	New	+$130K	0.07%	333
2025 Q1	–	Sell	-1,510	Closed	-$29.9K	–	991
2024 Q4	$29.9K	Buy	+1,510	New	+$16.7K	0.03%	706

Other funds holding MESO

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

R Squared's MESO Position: Q3 2025 in Review

R Squared sold out of Mesoblast (MESO) in Q3 2025, closing a stake of 11,571 shares — an estimated $126K sold.

R Squared first reported a position in MESO in Q4 2024 and held it in 2 quarters. The position peaked at $126K in Q2 2025. 68 funds tracked by Wall St. Rank hold MESO as of Q3 2025.

R Squared reported no remaining Mesoblast position as of Q3 2025 after selling out during the quarter.
R Squared sold 11,571 Mesoblast shares in Q3 2025, an estimated $126K.
R Squared first reported a position in Mesoblast in Q4 2024 and held it in 2 quarters.
R Squared's Mesoblast position peaked at $126K in Q2 2025.
68 funds tracked by Wall St. Rank held Mesoblast as of Q3 2025.

Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.